Table 4.
The TyG index in relation to CV events and MACEs
| Events (%) | Univariable model | Multivariable model* | |||
|---|---|---|---|---|---|
| HR (95%CI) | P value | HR (95%CI) | P value | ||
| CV events a | 141 (3.1) | 1.79 (1.37–2.35) | < 0.001 | 2.14 (1.50–3.04) | < 0.001 |
| T1 | 31 (2.1) | Reference | NA | Reference | NA |
| T2 | 51 (3.4) | 1.65 (1.06–2.58) | 0.027 | 1.68 (1.06–2.65) | 0.028 |
| T3 | 59 (3.9) | 1.92 (1.24–2.96) | 0.003 | 2.10 (1.28–3.47) | 0.004 |
| MACEs b | 117 (2.6) | 1.85 (1.37–2.49) | < 0.001 | 1.94 (1.33–2.84) | < 0.001 |
| T1 | 23 (1.5) | Reference | NA | Reference | NA |
| T2 | 43 (2.8) | 1.88 (1.13–3.12) | 0.015 | 1.87 (1.11–3.14) | 0.019 |
| T3 | 51 (3.4) | 2.23 (1.37–3.65) | 0.001 | 2.28 (1.30–4.01) | 0.004 |
aCV events were defined as a composite of CV death, nonfatal MI, and non-fatal stroke. bMACEs were defined as a composite of CV death and nonfatal MI. *Models adjusted for age, male sex, BMI, hypertension, diabetes mellitus, ACS presentation, histories of MI, TC, LDL-C, hsCRP, serum creatinine, LVEF, and three-vessel disease. CI, confidence interval; CV, cardiovascular; HR, hazard ratio; MACE, major adverse cardiac events; NA, not applicable. Other abbreviations as in Table 1